Investment Column: Poor numbers don't give Ashtead its credit

Balfour Beatty; Consort Medical


Our view: Buy

Share price: 110.2p (-3.5p)

The headline figures in Ashtead's full-year results were plainly uninspiring. The equipment hire company posted a 95 per cent decline in underlying profits before tax, while underlying revenues were down 25 per cent.

That said, the update was not quite as bad as some analysts had expected. Moreover, Ashtead has not been sitting around twiddling its thumbs; it has used the downturn to increase its market share, leaving it well placed to capitalise on the upturn – and this is where it gets interesting.

The company said market conditions appeared to be on the mend in the three months to the end of April. Its US market, in particular, showed signs of recovery, with leading indicators firming up. That bodes well for the future. Put the increased market share and the signs of recovery together and the headline figures begin to fade from the memory.

Those of a more bearish disposition might point to the UK, where the medium-term economic picture remains uncertain because of the looming fiscal squeeze. But the fact is that the storm clouds will eventually clear, and when they do, Ashtead will be in a strong position to make gains.

In the meantime, sales in America should help Ashtead to remain ahead of its peers. As it is, Ashtead has begun reinvesting in its fleet, funding the programme from operating cashflow. This should underpin gains in its US business, which is the focus of the reinvestment programme.

Promising stories like this are often undone by the valuation, but again, Ashtead's shares are not expensive. As UBS points out, on a mid-cycle basis, discounting back from estimates for 2013, the shares end up a on multiple of 4.2 times in terms of enterprise value to Ebitda. That compares favourably to usual mid-cycle metrics of 4.5 to 6 times. We think its worth investing in Ashtead now, before the recovery spreads its roots and the market re-rates the shares. Buy.

Balfour Beatty

Our view: Hold

Share price: 251p (-2.1p)

Balfour Beatty is still the largest construction company in Britain but recently it has been looking further afield to secure its growth. The push into the US seems to have reaped rewards – yesterday it announced a contract with a commuter rail project in Denver, Colorado, called Eagle.

The contract win was helped by its takeover of Parsons Brinkerhoff, one of the most recognisable names in the American construction industry, for $626m last September. Before that, 60 per cent of Balfour Beatty's revenues came from the UK (30 per cent from the US) and it was desperate to take some eggs out of its largest basket. The company's full-year results, published in March, showed that profits had dipped slightly, but the chief executive, Ian Tyler, remained bullish about the shape of the business and its prospects.

Analysts were happy that the company had beaten expectations, with many putting the performance down to the international structure of Balfour Beatty's business.

There could be significant opportunities for the company, and Panmure Gordon has it on an attractive price of 7.6 times estimated full-year earnings. Balfour Beatty is a good recovery play, but we are waiting to see further signs of a significant return of global infrastructure opportunities. Hold.

Consort Medical

Our view: Buy

Share price: 358p (-5p)

Consort Medical, a medical devices group, is not one for the faint-hearted. It announced its preliminary results yesterday, and blamed the weak US hospital market for a 6 per cent decline in pre-tax profits. The news followed a year when the company's shares fell by more than 10 per cent.

But those who prefer their investments in the fast lane may be tempted. Consort is pinning its hopes on its Bespak respiratory business, which managed to exceed expectations, despite the indifferent group numbers. The company, whose head office is in Hemel Hempstead, Hertfordshire, said Bespak products already helped to deliver medication to up to 100 million people with respiratory disease.

As with many recent company results, Consort's outlook is more positive than the numbers. However, if punters accept the potential of the Bespak products, there is a cheap stock on offer here. Trading on a 2010 price-earnings ratio of 9.2 times, Consort is inexpensive.

All of the above can be considered irrelevant, however. The dividend yield of 5.3 per cent alone justifies buying shares. Assuming that the company is not a basket case, and Consort isn't, investors should be supporters of the stock, so buy.

Start your day with The Independent, sign up for daily news emails
Arts and Entertainment
tvPoldark production team claims innocence of viewers' ab frenzy
Life and Style
Google marks the 81st anniversary of the Loch Ness Monster's most famous photograph
techIt's the 81st anniversary of THAT iconic photograph
News
Katie Hopkins makes a living out of courting controversy
people
News
General Election
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Pricing Analyst

£30 - 35k (DOE): Guru Careers: We are seeking a Pricing Analyst with experienc...

Ashdown Group: Treasury Assistant - Accounts Assistant - London, Old Street

£24000 - £26000 per annum + benefits : Ashdown Group: A highly successful, glo...

Ashdown Group: Sales Team Leader - Wakefield, West Yorkshire

£21000 - £24000 per annum: Ashdown Group: The Ashdown Group has been engaged b...

Ashdown Group: Head of Client Services - City of London, Old Street

£45000 - £50000 per annum + benefits : Ashdown Group: A highly successful, int...

Day In a Page

Revealed: Why Mohammed Emwazi chose the 'safe option' of fighting for Isis, rather than following his friends to al-Shabaab in Somalia

Why Mohammed Emwazi chose Isis

His friends were betrayed and killed by al-Shabaab
'The solution can never be to impassively watch on while desperate people drown'
An open letter to David Cameron: Building fortress Europe has had deadly results

Open letter to David Cameron

Building the walls of fortress Europe has had deadly results
Tory candidates' tweets not as 'spontaneous' as they seem - you don't say!

You don't say!

Tory candidates' election tweets not as 'spontaneous' as they appear
Mubi: Netflix for people who want to stop just watching trash

So what is Mubi?

Netflix for people who want to stop just watching trash all the time
The impossible job: how to follow Kevin Spacey?

The hardest job in theatre?

How to follow Kevin Spacey
Armenian genocide: To continue to deny the truth of this mass human cruelty is close to a criminal lie

Armenian genocide and the 'good Turks'

To continue to deny the truth of this mass human cruelty is close to a criminal lie
Lou Reed: The truth about the singer's upbringing beyond the biographers' and memoirists' myths

'Lou needed care, but what he got was ECT'

The truth about the singer's upbringing beyond
Migrant boat disaster: This human tragedy has been brewing for four years and EU states can't say they were not warned

This human tragedy has been brewing for years

EU states can't say they were not warned
Women's sportswear: From tackling a marathon to a jog in the park, the right kit can help

Women's sportswear

From tackling a marathon to a jog in the park, the right kit can help
Hillary Clinton's outfits will be as important as her policies in her presidential bid

Clinton's clothes

Like it or not, her outfits will be as important as her policies
NHS struggling to monitor the safety and efficacy of its services outsourced to private providers

Who's monitoring the outsourced NHS services?

A report finds that private firms are not being properly assessed for their quality of care
Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

Zac Goldsmith: 'I'll trigger a by-election over Heathrow'

The Tory MP said he did not want to stand again unless his party's manifesto ruled out a third runway. But he's doing so. Watch this space
How do Greek voters feel about Syriza's backtracking on its anti-austerity pledge?

How do Greeks feel about Syriza?

Five voters from different backgrounds tell us what they expect from Syriza's charismatic leader Alexis Tsipras
From Iraq to Libya and Syria: The wars that come back to haunt us

The wars that come back to haunt us

David Cameron should not escape blame for his role in conflicts that are still raging, argues Patrick Cockburn
Sam Baker and Lauren Laverne: Too busy to surf? Head to The Pool

Too busy to surf? Head to The Pool

A new website is trying to declutter the internet to help busy women. Holly Williams meets the founders